cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
0.780
+0.070 (9.84%)
Mar 6, 2026, 4:00 PM EST - Market closed
cbdMD Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2018 |
| Revenue | 19.09 | 19.19 | 19.48 | 24.16 | 35.4 | 44.48 | Upgrade
|
| Revenue Growth (YoY) | -0.66% | -1.50% | -19.35% | -31.77% | -20.41% | 6.20% | Upgrade
|
| Cost of Revenue | 7.52 | 7.22 | 7.49 | 9.18 | 13.07 | 14.5 | Upgrade
|
| Gross Profit | 11.57 | 11.97 | 12 | 14.98 | 22.34 | 29.99 | Upgrade
|
| Selling, General & Admin | 12.08 | 11.99 | 13.27 | 18.93 | 33.29 | 43.37 | Upgrade
|
| Research & Development | 0.03 | 0.03 | 0.04 | 0.17 | 0.63 | 1.42 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.77 | 0.77 | 0.7 | 1.4 | 0.88 | - | Upgrade
|
| Other Operating Expenses | 0.75 | 0.98 | 0.86 | 3.34 | 3.89 | 3.79 | Upgrade
|
| Operating Expenses | 13.93 | 14.13 | 15.31 | 24.25 | 39.65 | 49.6 | Upgrade
|
| Operating Income | -2.36 | -2.16 | -3.32 | -9.27 | -17.31 | -19.62 | Upgrade
|
| Interest Expense | - | - | -0.03 | - | - | -0.03 | Upgrade
|
| Interest & Investment Income | 0.03 | 0.03 | - | 0.06 | 0.02 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 0.24 | 0.03 | Upgrade
|
| EBT Excluding Unusual Items | -2.34 | -2.13 | -3.34 | -9.2 | -17.06 | -19.62 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.6 | - | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -56.67 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -0.7 | -0.03 | 0.55 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.09 | - | Upgrade
|
| Asset Writedown | - | - | - | -13.22 | -4.29 | - | Upgrade
|
| Other Unusual Items | -0 | 0.09 | -0.36 | 0.19 | 8.47 | -5.22 | Upgrade
|
| Pretax Income | -2.34 | -2.04 | -3.7 | -22.94 | -70.08 | -24.29 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | -0.9 | Upgrade
|
| Earnings From Continuing Operations | -2.34 | -2.04 | -3.7 | -22.94 | -70.08 | -23.39 | Upgrade
|
| Net Income | -2.34 | -2.04 | -3.7 | -22.94 | -70.08 | -23.39 | Upgrade
|
| Preferred Dividends & Other Adjustments | 1.38 | 2.33 | 4 | 4 | 4 | 2.55 | Upgrade
|
| Net Income to Common | -3.71 | -4.38 | -7.7 | -26.94 | -74.09 | -25.95 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 4 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 4 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 941.35% | 646.22% | 113.25% | 52.31% | 8.76% | 21.62% | Upgrade
|
| EPS (Basic) | -0.61 | -1.09 | -14.29 | -106.57 | -446.37 | -170.04 | Upgrade
|
| EPS (Diluted) | -0.61 | -1.09 | -14.29 | -106.57 | -446.40 | -170.04 | Upgrade
|
| Free Cash Flow | -2.13 | -1.64 | -0.54 | -4.6 | -15.66 | -14.44 | Upgrade
|
| Free Cash Flow Per Share | -0.35 | -0.41 | -1.01 | -18.20 | -94.33 | -94.59 | Upgrade
|
| Gross Margin | 60.59% | 62.37% | 61.57% | 62.01% | 63.09% | 67.41% | Upgrade
|
| Operating Margin | -12.37% | -11.27% | -17.02% | -38.37% | -48.89% | -44.10% | Upgrade
|
| Profit Margin | -19.45% | -22.80% | -39.55% | -111.53% | -209.26% | -58.34% | Upgrade
|
| Free Cash Flow Margin | -11.16% | -8.53% | -2.79% | -19.04% | -44.22% | -32.45% | Upgrade
|
| EBITDA | -1.29 | -1.04 | -2.17 | -7.47 | -15.48 | -18.6 | Upgrade
|
| EBITDA Margin | -6.75% | -5.40% | -11.12% | -30.92% | -43.72% | -41.81% | Upgrade
|
| D&A For EBITDA | 1.07 | 1.13 | 1.15 | 1.8 | 1.83 | 1.02 | Upgrade
|
| EBIT | -2.36 | -2.16 | -3.32 | -9.27 | -17.31 | -19.62 | Upgrade
|
| EBIT Margin | -12.37% | -11.27% | -17.02% | -38.37% | -48.89% | -44.10% | Upgrade
|
| Revenue as Reported | 19.09 | 19.19 | 19.48 | 24.16 | 35.4 | 44.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.